Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potentially Preventable Adverse Events in Ambulatory Interventional Radiology: Results from a National Multisite Retrospective Medical Record Review.
Ayeni C, Branch-Elliman W, Foster M, Higgins MCSS, Hederstedt K, Bart N, Mull HJ. Ayeni C, et al. Among authors: higgins mcss. Jt Comm J Qual Patient Saf. 2024 Nov 16:S1553-7250(24)00342-8. doi: 10.1016/j.jcjq.2024.11.006. Online ahead of print. Jt Comm J Qual Patient Saf. 2024. PMID: 39799069 No abstract available.
PRECIS-2 used as an implementation science tool for global environmental health: A cross-sectional evaluation of the Ecolectivos study protocol to reduce burning of household plastic waste in rural Guatemala.
Thompson LM, Ferguson A, Raheel H, Lovvorn AE, Hengstermann-Artiga M, Lopez MR, Higgins M, Saikawa E, Handley MA. Thompson LM, et al. Among authors: higgins m. PLoS One. 2024 Dec 30;19(12):e0316161. doi: 10.1371/journal.pone.0316161. eCollection 2024. PLoS One. 2024. PMID: 39775435 Free PMC article.
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic AHF, Kress A, Carter-Timofte ME, Holm E, van der Horst D, Kollmann CF, Liu Z, Wang C, Hoang HD, Kovalenko E, Chrysopoulou M, Twayana KS, Ottosen RN, Svenningsen EB, Begnini F, Kiib AE, Kromm FEH, Weiss HJ, Di Carlo D, Muscolini M, Higgins M, van der Heijden M, Arulanandam R, Bardoul A, Tong T, Ozsvar A, Hou WH, Schack VR, Holm CK, Zheng Y, Ruzek M, Kalucka J, de la Vega L, Elgaher WAM, Korshoej AR, Lin R, Hiscott J, Poulsen TB, O'Neill LA, Roy DG, Rinschen MM, van Montfoort N, Diallo JS, Farin HF, Alain T, Olagnier D. Kurmasheva N, et al. Among authors: higgins m. Nat Commun. 2024 Dec 19;15(1):10698. doi: 10.1038/s41467-024-55044-w. Nat Commun. 2024. PMID: 39702301 Free PMC article. No abstract available.
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU; DESTINY-Breast12 study group. Harbeck N, et al. Among authors: higgins mj. Nat Med. 2024 Dec;30(12):3780. doi: 10.1038/s41591-024-03349-0. Nat Med. 2024. PMID: 39653780 Free PMC article. No abstract available.
1,646 results